Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A comparison of antigen-specific T cell responses induced by six novel tuberculosis vaccine candidates
Miguel Rodo, Virginie Rozot, Elisa Nemes, et al.
PLoS Pathogens (2019) Vol. 15, Iss. 3, pp. e1007643-e1007643
Open Access | Times Cited: 79

Showing 26-50 of 79 citing articles:

Epitope promiscuity and population coverage of Mycobacterium tuberculosis protein antigens in current subunit vaccines under development
Edison Ong, Yongqun He, Zhenhua Yang
Infection Genetics and Evolution (2020) Vol. 80, pp. 104186-104186
Closed Access | Times Cited: 30
Cell-Mediated Immune Responses to in vivo-Expressed and Stage-Specific Mycobacterium tuberculosis Antigens in Latent and Active Tuberculosis Across Different Age Groups
Mariateresa Coppola, Raquel Villar-Hernández, Krista E. van Meijgaarden, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 30
An integrated computational framework to design a multi-epitopes vaccine against Mycobacterium tuberculosis
Aqel Albutti
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 26
Immunogenicity and Safety of the M72/AS01E Candidate Vaccine Against Tuberculosis: A Meta-Analysis
Zhenhua Ji, Miaomiao Jian, Taigui Chen, et al.
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 26
Immunological Characterization of Proteins Expressed by Genes Located in Mycobacterium tuberculosis-Specific Genomic Regions Encoding the ESAT6-like Proteins
Abu Salim Mustafa
Vaccines (2021) Vol. 9, Iss. 1, pp. 27-27
Open Access | Times Cited: 23
Immunogenicity and efficacy analyses of EPC002, ECA006, and EPCP009 protein subunit combinations as tuberculosis vaccine candidates
Ruihuan Wang, Xueting Fan, Yi Jiang, et al.
Vaccine (2023) Vol. 41, Iss. 26, pp. 3836-3846
Closed Access | Times Cited: 8
Whole genome sequencing, analyses of drug resistance-conferring mutations, and correlation with transmission of Mycobacterium tuberculosis carrying katG-S315T in Hanoi, Vietnam
Nguyen Thi Le Hang, Minako Hijikata, Shinji Maeda, et al.
Scientific Reports (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 24
Rescuing ESAT-6 Specific CD4 T Cells From Terminal Differentiation Is Critical for Long-Term Control of Murine Mtb Infection
Helena Strand Clemmensen, Niels Peter Hell Knudsen, Rolf Billeskov, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 22
Advancing Adjuvants for Mycobacterium tuberculosis Therapeutics
Ana Beatriz Enriquez, Angelo Izzo, Shannon M. Miller, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 20
A peptide-based vaccine ACP derived from antigens of Mycobacterium tuberculosis induced Th1 response but failed to enhance the protective efficacy of BCG in mice
Wenping Gong, Yan Liang, Jie Mi, et al.
Indian Journal of Tuberculosis (2021) Vol. 69, Iss. 4, pp. 482-495
Closed Access | Times Cited: 19
Insight Into Novel Anti-tuberculosis Vaccines by Using Immunoinformatics Approaches
Zafran Khan, Daniya Ualiyeva, Obed Boadi Amissah, et al.
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 13
Immunization with Mycobacterium tuberculosis–Specific Antigens Bypasses T Cell Differentiation from Prior Bacillus Calmette–Guérin Vaccination and Improves Protection in Mice
Claus Aagaard, Niels Peter Hell Knudsen, Iben Sohn, et al.
The Journal of Immunology (2020) Vol. 205, Iss. 8, pp. 2146-2155
Open Access | Times Cited: 20
Is mapping the BCG vaccine‐induced immune responses the key to improving the efficacy against tuberculosis?
Rebecca Kuan, Kaylin Muskat, Bjoern Peters, et al.
Journal of Internal Medicine (2020) Vol. 288, Iss. 6, pp. 651-660
Open Access | Times Cited: 20
CD4+CCR6+ T cells dominate the BCG-induced transcriptional signature
Akul Singhania, Paige Dubelko, Rebecca Kuan, et al.
EBioMedicine (2021) Vol. 74, pp. 103746-103746
Open Access | Times Cited: 16
The next frontier in vaccine design: blending immune correlates of protection into rational vaccine design
Carl Britto, Galit Alter
Current Opinion in Immunology (2022) Vol. 78, pp. 102234-102234
Open Access | Times Cited: 12
A novel adjuvant formulation induces robust Th1/Th17 memory and mucosal recall responses in Non-Human Primates
Joshua S. Woodworth, Vanessa Contreras, Dennis Christensen, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 6
Antibodies Targeting the Cell Wall Induce Protection against Virulent Mycobacterium bovis Infection
Mengjin Qu, Zhengmin Liang, Yulan Chen, et al.
Microbiology Spectrum (2023) Vol. 11, Iss. 2
Open Access | Times Cited: 6
Activation Phenotype of Mycobacterium tuberculosis-Specific CD4+ T Cells Promoting the Discrimination Between Active Tuberculosis and Latent Tuberculosis Infection
Ying Luo, Ying Xue, Liyan Mao, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 14
Mucosal Vaccination with Cyclic Dinucleotide Adjuvants Induces Effective T Cell Homing and IL-17–Dependent Protection against Mycobacterium tuberculosis Infection
Robyn M. Jong, Erik Van Dis, Samuel B. Berry, et al.
The Journal of Immunology (2021) Vol. 208, Iss. 2, pp. 407-419
Open Access | Times Cited: 14
B21 DNA vaccine expressing ag85b, rv2029c, and rv1738 confers a robust therapeutic effect against latent Mycobacterium tuberculosis infection
Shufeng Weng, Jinyi Zhang, Huixia Ma, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 8
Role of MHC class I pathways in Mycobacterium tuberculosis antigen presentation
Karolina D. Witt
Frontiers in Cellular and Infection Microbiology (2023) Vol. 13
Open Access | Times Cited: 4
Exploring the immunogenicity of Rv2201-519: A T-cell epitope-based antigen derived from Mycobacterium tuberculosis AsnB with implications for tuberculosis infection detection and vaccine development
Xiuli Luan, Xueting Fan, Guilian Li, et al.
International Immunopharmacology (2024) Vol. 129, pp. 111542-111542
Closed Access | Times Cited: 1
TB and HIV induced immunosenescence: where do vaccines play a role?
Mona Singh, Bhumika Patel, Michael Seo, et al.
Frontiers in Aging (2024) Vol. 5
Open Access | Times Cited: 1
Reappraising the Role of T Cell–Derived IFN-γ in Restriction of Mycobacterium tuberculosis in the Murine Lung
Karolina Maciag, Courtney R. Plumlee, Sara Cohen, et al.
The Journal of Immunology (2024) Vol. 213, Iss. 3, pp. 339-346
Open Access | Times Cited: 1
A multistage protein subunit vaccine as BCG-booster confers protection against Mycobacterium tuberculosis infection in murine models
Zhenyan Chen, Ying Zhang, Juan Wu, et al.
International Immunopharmacology (2024) Vol. 139, pp. 112811-112811
Closed Access | Times Cited: 1

Scroll to top